Intracelluar drug delivery specialist ViaNautis Bio Ltd will use US$25 raised in a Series A financing to push applications of its bionic nanoparticle platform polyNaut.
https://european-biotechnology.com/wp-content/uploads/2024/04/Vianautis-SomaServe.jpg168300Thomas Gabrielczyk/wp-content/uploads/2024/07/EBM_quer_Logo_2022_400px_wihte.pngThomas Gabrielczyk2023-11-13 08:48:332024-07-09 13:42:23ViaNautis Bio Ltd closes US$25m Series A financing